PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A randomized, double-blind, placebo-controlled trial evaluated the effect of aqueous extract on subjects with mildly to moderately elevated ALT levels [PMID:29486131].
One month of agrimony tea consumption in healthy volunteers significantly lowered interleukin 6 levels and elevated plasma total antioxidant capacity [PMID:23078582].
Agrimony tea supplementation was associated with an improved lipid profile, specifically increased high density lipoprotein (HDL) cholesterol [PMID:23078582].
Extract administered to rats with cisplatin-induced neuropathy showed anti-nociceptive effects, including higher withdrawal thresholds in paw-withdrawal tests [PMID:28487904].
Aqueous extract induced myofibroblast-like phenotype and enhanced extracellular matrix deposition, improving wound tensile strength and contraction rates in rats [PMID:35478102].
Evidence summary
PubMed sources
- 1.PMID: 37895122 (2023) — Plant Extracts as Skin Care and Therapeutic Agents. · International journal of molecular sciences
- 2.PMID: 36145771 (2022) — Phytochemical and Pharmacological Research in Agrimonia eupatoria L. Herb Extract with Anti-Inflammatory and Hepatoprotective Properties. · Plants (Basel, Switzerland)
- 3.PMID: 35752261 (2022) — Agrimonia eupatoria L.: An integrative perspective on ethnomedicinal use, phenolic composition and pharmacological activity. · Journal of ethnopharmacology
- 4.PMID: 33646008 (2020) — The therapeutic effects of Agrimonia eupatoria L. · Physiological research
- 5.PMID: 36836930 (2023) — In Situ Gel with Silver Nanoparticles Prepared Using Agrimonia eupatoria L. Shows Antibacterial Activity.